Cargando…
EGFR-TKI联合放疗治疗晚期非小细胞肺癌的研究进展
Lung cancer is one of the most common malignant tumor in the world, severely threatening human life. Recently, targeted therapy such as the epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) made huge progress in treatment of lung cancer. EGFR-TKIs, with its high selectivity and...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000013/ https://www.ncbi.nlm.nih.gov/pubmed/24758913 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.12 |